Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19

Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19

Teicoplanin is a glycopeptide antibiotic effective against several bacterial infections, has exhibited promising therapeutic efficiency against COVID-19 in vitro<i>,</i> and the rationale for its use in COVID-19 is yet to be recognized. Hence, in this study a number of molecular modeling...

Full description

Bibliographic Details
Main Author:	Faizul Azam
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Antibiotics
Subjects:	SARS-CoV-2 teicoplanin docking molecular dynamics MM/GBSA
Online Access:	https://www.mdpi.com/2079-6382/10/7/856

Similar Items

Peptide Derivatives of the Zonulin Inhibitor Larazotide (AT1001) as Potential Anti SARS-CoV-2: Molecular Modelling, Synthesis and Bioactivity Evaluation
by: Simone Di Micco, et al.
Published: (2021-08-01)

Multi-Targeting Approach in Selection of Potential Molecule for COVID-19 Treatment
by: Varalakshmi Velagacherla, et al.
Published: (2023-01-01)

Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?
by: Vladimir Vimberg
Published: (2021-11-01)

Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies
by: Dipesh Kumar Verma, et al.
Published: (2022-12-01)

Computational Insights Into the Effects of the R190K and N121Q Mutations on the SARS-CoV-2 Spike Complex With Biliverdin
by: Zhiyuan Qu, et al.
Published: (2021-12-01)

Glycopeptide Antibiotic Teicoplanin Inhibits Cell Entry of SARS-CoV-2 by Suppressing the Proteolytic Activity of Cathepsin L
by: Fei Yu, et al.
Published: (2022-04-01)

A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from <i>Xylopia vielana</i> Targeting B-Raf Kinase
by: Syed Shams ul Hassan, et al.
Published: (2022-01-01)

Investigating the potential anticancer activities of antibiotics as topoisomerase II inhibitors and DNA intercalators: in vitro, molecular docking, molecular dynamics, and SAR studies
by: Faten Farouk, et al.
Published: (2023-12-01)

In Silico Investigations on the Synergistic Binding Mechanism of Functional Compounds with Beta-Lactoglobulin
by: Tong Meng, et al.
Published: (2024-02-01)

In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
by: Simone Di Micco, et al.
Published: (2021-01-01)

Potent Bioactive Compounds From Seaweed Waste to Combat Cancer Through Bioinformatics Investigation
by: Kaushik Kumar Bharadwaj, et al.
Published: (2022-04-01)

Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 M<sup>pro</sup> Main Protease Inhibitors
by: Maria Nuria Peralta-Moreno, et al.
Published: (2023-04-01)

High-Affinity Antibodies Designing of SARS-CoV-2 Based on Molecular Dynamics Simulations
by: Zihui Tian, et al.
Published: (2022-12-01)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
by: Camryn Carter, et al.
Published: (2023-10-01)

Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors
by: Menier Al-Anazi, et al.
Published: (2018-12-01)

Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors
by: Ying Fu, et al.
Published: (2020-08-01)

Evaluation of new antihypertensive drugs designed in silico using Thermolysin as a target
by: Desmond MacLeod-Carey, et al.
Published: (2020-05-01)

In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach
by: Muthu Kumar Thirunavukkarasu, et al.
Published: (2021-12-01)

Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies
by: Abdulrahim A. Alzain, et al.
Published: (2024-01-01)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
by: Siddharth Sinha, et al.
Published: (2021-12-01)

Computational Modeling on Aquaporin-3 as Skin Cancer Target: A Virtual Screening Study
by: Dharmendra Kumar Yadav, et al.
Published: (2020-04-01)

Structure-Based Design, Docking and Binding Free Energy Calculations of A366 Derivatives as Spindlin1 Inhibitors
by: Chiara Luise, et al.
Published: (2021-05-01)

Anticancer potential of phytochemicals from Oroxylum indicum targeting Lactate Dehydrogenase A through bioinformatic approach
by: Sheikh Sunzid Ahmed, et al.
Published: (2023-01-01)

Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors
by: Ling Ma, et al.
Published: (2023-02-01)

Interactions between DC-SIGN and the envelope protein from Dengue and Zika viruses: a structural perspective based on molecular dynamics and MM/GBSA analyses
by: Bruno Stein Barbosa Menechino, et al.
Published: (2023-12-01)

In-silico study MM/GBSA binding free energy and molecular dynamics simulation of some designed remdesivir derivatives as the inhibitory potential of SARS-CoV-2 main protease
by: Maryam Abbasi, et al.
Published: (2024-01-01)

Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights
by: Sreenivasulu Godesi, et al.
Published: (2023-06-01)

Screening a Panel of Topical Ophthalmic Medications against MMP-2 and MMP-9 to Investigate Their Potential in Keratoconus Management
by: Amany Belal, et al.
Published: (2022-06-01)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M<sup>pro</sup> Inhibitors
by: Enrico M. A. Fassi, et al.
Published: (2023-03-01)

The anticancer potential of chemical constituents of Moringa oleifera targeting CDK-2 inhibition in estrogen receptor positive breast cancer using in-silico and in vitro approches
by: Rida Sultan, et al.
Published: (2023-11-01)

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
by: Rajveer Singh, et al.
Published: (2020-10-01)

Exploring the Interaction between Vancomycin/Teicoplanin and Receptor Binding Domain (RBD) of SARS-CoV-2
by: Wen-Tao Tao, et al.
Published: (2021-01-01)

Antioxidant evaluation and computational prediction of prospective drug-like compounds from polyphenolic-rich extract of Hibiscus cannabinus L. seed as antidiabetic and neuroprotective targets: assessment through in vitro and in silico studies
by: Olakunle Bamikole Afolabi, et al.
Published: (2023-06-01)

Investigating the Mechanism of Action of Anti-Dengue Compounds as Potential Binders of Zika Virus RNA-Dependent RNA Polymerase
by: Thamir A. Alandijany, et al.
Published: (2023-07-01)

Identification of Selective BRD9 Inhibitor via Integrated Computational Approach
by: Maria Mushtaq Ali, et al.
Published: (2022-11-01)

In silico studies of Ruellia tuberosa L. compounds as aldose reductase, dipeptidyl peptidase 4, and α-glucosidase inhibitors against type 2 diabetes mellitus
by: Ekowati Retnaningtyas, et al.
Published: (2024-07-01)

Teicoplanin-Induced Anaphylactic Reaction in Children: A Case Report
by: Godwin Oligbu, et al.
Published: (2018-10-01)

Clinical Pharmacology of Teicoplanin in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici
Published: (2016-10-01)

Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease
by: Adewale Oluwaseun Fadaka, et al.
Published: (2021-08-01)

Demystifying the Molecular Basis of Pyrazoloquinolinones Recognition at the Extracellular α1+/β3- Interface of the GABAA Receptor by Molecular Modeling
by: Natesh Singh, et al.
Published: (2020-09-01)